{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:51:14Z","timestamp":1790419874464,"version":"4.1.0"},"reference-count":277,"publisher":"BMJ","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sarcoidosis is a highly variable granulomatous multisystem syndrome. It affects individuals in the prime years of life; both the frequency and severity of sarcoidosis are greater in economically disadvantaged populations. The diagnosis, assessment, and management of pulmonary sarcoidosis have evolved as new technologies and therapies have been adopted. Transbronchial needle aspiration guided by endobronchial ultrasound has replaced mediastinoscopy in many centers. Advanced imaging modalities, such as fluorodeoxyglucose positron emission tomography scanning, and the widespread availability of magnetic resonance imaging have led to more sensitive assessment of organ involvement and disease activity. Although several new insights about the pathogenesis of sarcoidosis exist, no new therapies have been specifically developed for use in the disease. The current or proposed use of immunosuppressive medications for sarcoidosis has been extrapolated from other disease states; various novel pathways are currently under investigation as therapeutic targets. Coupled with the growing recognition of corticosteroid toxicities for managing sarcoidosis, the use of corticosteroid sparing anti-sarcoidosis medications is likely to increase. Besides treatment of granulomatous inflammation, recognition and management of the non-granulomatous complications of pulmonary sarcoidosis are needed for optimal outcomes in patients with advanced disease.<\/jats:p>","DOI":"10.1136\/bmj.l5553","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T16:15:11Z","timestamp":1571760911000},"page":"l5553","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":47,"title":["New advances in the management of pulmonary sarcoidosis"],"prefix":"10.1136","author":[{"given":"Daniel A","family":"Culver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A","family":"Judson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"key":"key20191023000315_ref1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.10.2104046"},{"key":"key20191023000315_ref2","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref3","volume-title":"Sarcoidosis.","author":"Siltzbach","year":"1980"},{"key":"key20191023000315_ref4","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.2.406"},{"key":"key20191023000315_ref5","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a121609"},{"key":"key20191023000315_ref6","first-page":"44","article-title":"Sarcoidosis in coroner\u2019s autopsies: a critical evaluation of diagnosis and prevalence from Cuyahoga County, Ohio","volume":"15","author":"Reid","year":"1998","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref7","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201508-568BC"},{"key":"key20191023000315_ref8","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201511-760OC"},{"key":"key20191023000315_ref9","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.5.1431"},{"key":"key20191023000315_ref10","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00197808"},{"key":"key20191023000315_ref11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00477-2016"},{"key":"key20191023000315_ref12","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009096"},{"key":"key20191023000315_ref13","first-page":"55","article-title":"Epidemiology of sarcoidosis recorded in 2006-2010 in the Silesian voivodeship on the basis of routine medical reporting","volume":"21","author":"Kowalska","year":"2014","journal-title":"Ann Agric Environ Med"},{"key":"key20191023000315_ref14","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200607-138MS"},{"key":"key20191023000315_ref15","first-page":"125","article-title":"HLA and environmental interactions in sarcoidosis","volume":"25","author":"Rossman","year":"2008","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref16","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a114313"},{"key":"key20191023000315_ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2007.01062.x"},{"key":"key20191023000315_ref18","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.98.12051197"},{"key":"key20191023000315_ref19","first-page":"153","article-title":"Epidemiology of sarcoidosis in Catalonia: 1979-1989","volume":"13","author":"Fit\u00e9","year":"1996","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref20","first-page":"241","article-title":"Seasonality of sarcoidosis: the \u2018heat\u2019 is on\u2026","volume":"30","author":"Gupta","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref21","first-page":"155","article-title":"An analysis of seasonality of sarcoidosis in the United States veteran population: 2000-2007","volume":"29","author":"Gerke","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref22","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-209032"},{"key":"key20191023000315_ref23","first-page":"111","article-title":"Sarcoidosis in Ireland: regional differences in prevalence and mortality from 1996-2005","volume":"27","author":"Nicholson","year":"2010","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref24","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009998"},{"key":"key20191023000315_ref25","doi-asserted-by":"publisher","DOI":"10.1136\/thx.42.6.427"},{"key":"key20191023000315_ref26","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.11.2106001"},{"key":"key20191023000315_ref27","doi-asserted-by":"publisher","DOI":"10.1136\/thx.39.1.14"},{"key":"key20191023000315_ref28","doi-asserted-by":"publisher","DOI":"10.1378\/chest.116.5.1183"},{"key":"key20191023000315_ref29","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/148.4_Pt_1.974"},{"key":"key20191023000315_ref30","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/165.8.630"},{"key":"key20191023000315_ref31","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200402-249OC"},{"key":"key20191023000315_ref32","doi-asserted-by":"publisher","DOI":"10.1097\/01.jom.0000155711.88781.91"},{"key":"key20191023000315_ref33","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.5.1527"},{"key":"key20191023000315_ref34","first-page":"49","article-title":"Photocopier exposure and risk of sarcoidosis in African-American sibs","volume":"21","author":"Rybicki","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref35","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2114"},{"key":"key20191023000315_ref36","doi-asserted-by":"publisher","DOI":"10.1053\/rmed.2000.0827"},{"key":"key20191023000315_ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.10.003"},{"key":"key20191023000315_ref38","doi-asserted-by":"publisher","DOI":"10.1016\/S1047-2797(00)00179-4"},{"key":"key20191023000315_ref39","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-1099"},{"key":"key20191023000315_ref40","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws145"},{"key":"key20191023000315_ref41","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2016.1196135"},{"key":"key20191023000315_ref42","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-5231(05)70416-0"},{"key":"key20191023000315_ref43","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-5231(05)70417-2"},{"key":"key20191023000315_ref44","doi-asserted-by":"publisher","DOI":"10.1378\/chest.15-1061"},{"key":"key20191023000315_ref45","first-page":"A4815","article-title":"Genotyping increases the yield of angiotensin-converting enzyme in sarcoidosis--a systematic review","volume":"61","author":"Fl\u00f8e","year":"2014","journal-title":"Dan Med J"},{"key":"key20191023000315_ref46","doi-asserted-by":"publisher","DOI":"10.1378\/chest.124.1.186"},{"key":"key20191023000315_ref47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2003.01230.x"},{"key":"key20191023000315_ref48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2007.03423.x"},{"key":"key20191023000315_ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9754-4"},{"key":"key20191023000315_ref50","first-page":"194","article-title":"Common chitotriosidase duplication gene polymorphism and clinical outcome status in sarcoidosis","volume":"32","author":"Harlander","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref51","doi-asserted-by":"publisher","DOI":"10.1007\/PL00007637"},{"key":"key20191023000315_ref52","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200905-0696OC"},{"key":"key20191023000315_ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2017.03.009"},{"key":"key20191023000315_ref54","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200303-459OC"},{"key":"key20191023000315_ref55","doi-asserted-by":"publisher","DOI":"10.1086\/378097"},{"key":"key20191023000315_ref56","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200807-1082OC"},{"key":"key20191023000315_ref57","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(99)00050-6"},{"key":"key20191023000315_ref58","doi-asserted-by":"publisher","DOI":"10.1038\/ng.198"},{"key":"key20191023000315_ref59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043907"},{"key":"key20191023000315_ref60","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201503-0418OC"},{"key":"key20191023000315_ref61","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200803-490OC"},{"key":"key20191023000315_ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.06.017"},{"key":"key20191023000315_ref63","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201106-1143OC"},{"key":"key20191023000315_ref64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044818"},{"key":"key20191023000315_ref65","first-page":"231","article-title":"Mortality in sarcoidosis. A changing pattern of the causes of death","volume":"62","author":"Huang","year":"1981","journal-title":"Eur J Respir Dis"},{"key":"key20191023000315_ref66","first-page":"167","article-title":"Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations","volume":"119","author":"Perry","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"key20191023000315_ref67","first-page":"275","article-title":"Causes of death in patients with chronic sarcoidosis","volume":"33","author":"Hu","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref68","doi-asserted-by":"publisher","DOI":"10.1378\/chest.15-0615"},{"key":"key20191023000315_ref69","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e3283486d52"},{"key":"key20191023000315_ref70","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3182785a2d"},{"key":"key20191023000315_ref71","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00226911"},{"key":"key20191023000315_ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.10.014"},{"key":"key20191023000315_ref73","first-page":"154","article-title":"Clinical bronchiectasis complicating pulmonary sarcoidosis: case series of seven patients","volume":"19","author":"Lewis","year":"2002","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref74","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.5.1246"},{"key":"key20191023000315_ref75","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2017.1281745"},{"key":"key20191023000315_ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2015.08.006"},{"key":"key20191023000315_ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2012.11.011"},{"key":"key20191023000315_ref78","first-page":"S37","article-title":"Pulmonary fibrosis of sarcoidosis. New approaches, old ideas","volume":"29","author":"Moller","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"key20191023000315_ref79","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2010.01590.x"},{"key":"key20191023000315_ref80","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00010209"},{"key":"key20191023000315_ref81","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.6.1584"},{"key":"key20191023000315_ref82","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1013660"},{"key":"key20191023000315_ref83","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1013504"},{"key":"key20191023000315_ref84","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-201786"},{"key":"key20191023000315_ref85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009088"},{"key":"key20191023000315_ref86","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-14-121"},{"key":"key20191023000315_ref87","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-1178"},{"key":"key20191023000315_ref88","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-015-1047-6"},{"key":"key20191023000315_ref89","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001095"},{"key":"key20191023000315_ref90","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-1359"},{"key":"key20191023000315_ref91","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00227014"},{"key":"key20191023000315_ref92","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00055213"},{"key":"key20191023000315_ref93","first-page":"372","article-title":"Role of serial F-18 FDG PET\/CT scans in assessing treatment response and predicting relapses in patients with symptomatic sarcoidosis","volume":"33","author":"Maturu","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref94","first-page":"94","article-title":"The role of somatostatin and somatostatin analogs in the pathophysiology of the human immune system","volume":"26","author":"Dalm","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"key20191023000315_ref95","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1999.00498.x"},{"key":"key20191023000315_ref96","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000000977"},{"key":"key20191023000315_ref97","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12799"},{"key":"key20191023000315_ref98","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-016-1095-6"},{"key":"key20191023000315_ref99","first-page":"56","article-title":"Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force","volume":"28","author":"Baughman","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref100","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2018.10.004"},{"key":"key20191023000315_ref101","doi-asserted-by":"crossref","unstructured":"Gerke AK, Judson MA, Cozier YC, et al. Disease burden and variability in sarcoidosis. Ann Am Thorac Soc 2017;14(Supplement_6):S421-S28.","DOI":"10.1513\/AnnalsATS.201707-564OT"},{"key":"key20191023000315_ref102","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(93)90150-Y"},{"key":"key20191023000315_ref103","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.07.008"},{"key":"key20191023000315_ref104","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(13)70276-5"},{"key":"key20191023000315_ref105","first-page":"496","article-title":"Corticosteroid therapy in sarcoidosis. A five-year, controlled follow-up study","volume":"87","author":"Zaki","year":"1987","journal-title":"N Y State J Med"},{"key":"key20191023000315_ref106","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(67)90493-X"},{"key":"key20191023000315_ref107","first-page":"215","article-title":"Corticosteroid therapy of pulmonary sarcoidosis. A prospective evaluation of alternate day and daily dosage in stage II disease","volume":"60","author":"Selroos","year":"1979","journal-title":"Scand J Respir Dis"},{"key":"key20191023000315_ref108","doi-asserted-by":"publisher","DOI":"10.1164\/arrd.1973.107.4.609"},{"key":"key20191023000315_ref109","doi-asserted-by":"publisher","DOI":"10.1378\/chest.116.2.424"},{"key":"key20191023000315_ref110","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e3181b97635"},{"key":"key20191023000315_ref111","first-page":"280","article-title":"The indications for the treatment of sarcoidosis: Wells Law","volume":"34","author":"Baughman","year":"2017","journal-title":"SVDLD"},{"key":"key20191023000315_ref112","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2016.12.005"},{"key":"key20191023000315_ref113","doi-asserted-by":"publisher","DOI":"10.1378\/chest.111.3.623"},{"key":"key20191023000315_ref114","first-page":"1045","article-title":"Dose-dependent effect of glucocorticosteroids on pulmonary defenses in a steroid-resistant host","volume":"126","author":"Blackwood","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"key20191023000315_ref115","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3642832"},{"key":"key20191023000315_ref116","doi-asserted-by":"publisher","DOI":"10.1097\/00063198-199909000-00005"},{"key":"key20191023000315_ref117","doi-asserted-by":"publisher","DOI":"10.1378\/chest.82.1.84"},{"key":"key20191023000315_ref118","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1986.tb18548.x"},{"key":"key20191023000315_ref119","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.3.238"},{"key":"key20191023000315_ref120","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.1.24"},{"key":"key20191023000315_ref121","first-page":"201","article-title":"Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis","volume":"30","author":"Drake","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref122","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2013.01.001"},{"key":"key20191023000315_ref123","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcl038"},{"key":"key20191023000315_ref124","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199903000-00001"},{"key":"key20191023000315_ref125","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007595"},{"key":"key20191023000315_ref126","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2009.12.009"},{"key":"key20191023000315_ref127","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0413"},{"key":"key20191023000315_ref128","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref129","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2015.08.015"},{"key":"key20191023000315_ref130","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2017.10.022"},{"key":"key20191023000315_ref131","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02089-2017"},{"key":"key20191023000315_ref132","doi-asserted-by":"publisher","DOI":"10.1136\/thx.41.6.473"},{"key":"key20191023000315_ref133","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1986.tb18549.x"},{"key":"key20191023000315_ref134","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110851"},{"key":"key20191023000315_ref135","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2017.09.003"},{"key":"key20191023000315_ref136","first-page":"60","article-title":"Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial","volume":"17","author":"Baughman","year":"2000","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref137","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151940"},{"key":"key20191023000315_ref138","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-017-0076-4"},{"key":"key20191023000315_ref139","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01397-2017"},{"key":"key20191023000315_ref140","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00199-X"},{"key":"key20191023000315_ref141","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-017-1131-x"},{"key":"key20191023000315_ref142","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1358\/dot.2009.45.7.1384878","article-title":"Mycophenolate mofetil: An update","volume":"45","author":"Villarroel","year":"2009","journal-title":"Drugs Today (Barc)"},{"key":"key20191023000315_ref143","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2010.5"},{"key":"key20191023000315_ref144","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e3283642ad0"},{"key":"key20191023000315_ref145","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-1728"},{"key":"key20191023000315_ref146","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00195010"},{"key":"key20191023000315_ref147","first-page":"43","article-title":"Leflunomide for chronic sarcoidosis","volume":"21","author":"Baughman","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref148","first-page":"107","article-title":"Azathioprine treatment of chronic pulmonary sarcoidosis","volume":"2","author":"Pacheco","year":"1985","journal-title":"Sarcoidosis"},{"key":"key20191023000315_ref149","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1995.00430080088011"},{"key":"key20191023000315_ref150","doi-asserted-by":"publisher","DOI":"10.1002\/anr.1780320202"},{"key":"key20191023000315_ref151","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1282"},{"key":"key20191023000315_ref152","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.6435"},{"key":"key20191023000315_ref153","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61302-7"},{"key":"key20191023000315_ref154","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22948"},{"key":"key20191023000315_ref155","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208840"},{"key":"key20191023000315_ref156","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000001064"},{"key":"key20191023000315_ref157","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.09.002"},{"key":"key20191023000315_ref158","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.10.029"},{"key":"key20191023000315_ref159","first-page":"170","article-title":"Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study","volume":"34","author":"Owen","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"key20191023000315_ref160","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2014.09.013"},{"key":"key20191023000315_ref161","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003431"},{"key":"key20191023000315_ref162","doi-asserted-by":"publisher","DOI":"10.1111\/j.1752-699X.2007.00023.x"},{"key":"key20191023000315_ref163","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.15.8093"},{"key":"key20191023000315_ref164","doi-asserted-by":"publisher","DOI":"10.1002\/art.23447"},{"key":"key20191023000315_ref165","doi-asserted-by":"publisher","DOI":"10.1016\/S0012-3692(15)50471-6"},{"key":"key20191023000315_ref166","doi-asserted-by":"publisher","DOI":"10.1378\/chest.124.1.177"},{"key":"key20191023000315_ref167","first-page":"91","article-title":"Practical eminence and experience-based recommendations for use of TNF-\u03b1 inhibitors in sarcoidosis","volume":"31","author":"Drent","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref168","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00000914"},{"key":"key20191023000315_ref169","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2018.02.009"},{"key":"key20191023000315_ref170","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200603-402OC"},{"key":"key20191023000315_ref171","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00051907"},{"key":"key20191023000315_ref172","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-1347"},{"key":"key20191023000315_ref173","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2008.08.016"},{"key":"key20191023000315_ref174","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.11.019"},{"key":"key20191023000315_ref175","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.10.056"},{"key":"key20191023000315_ref176","doi-asserted-by":"publisher","DOI":"10.1002\/art.39667"},{"key":"key20191023000315_ref177","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.04.011"},{"key":"key20191023000315_ref178","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.1.9809024"},{"key":"key20191023000315_ref179","doi-asserted-by":"publisher","DOI":"10.1100\/tsw.2010.173"},{"key":"key20191023000315_ref180","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-017-9994-4"},{"key":"key20191023000315_ref181","first-page":"35","article-title":"Chlorambucil treatment of sarcoidosis","volume":"8","author":"Israel","year":"1991","journal-title":"Sarcoidosis"},{"key":"key20191023000315_ref182","doi-asserted-by":"publisher","DOI":"10.1378\/chest.78.1.36"},{"key":"key20191023000315_ref183","first-page":"51","article-title":"The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosis","volume":"23","author":"Judson","year":"2006","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref184","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2012.03.005"},{"key":"key20191023000315_ref185","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.155.5.9154873"},{"key":"key20191023000315_ref186","first-page":"121","article-title":"Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis","volume":"26","author":"Park","year":"2009","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref187","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201206-1024OC"},{"key":"key20191023000315_ref188","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00224513"},{"key":"key20191023000315_ref189","first-page":"2","article-title":"New advances in the development of sarcoidosis models: a synopsis of a symposium sponsored by the Foundation for Sarcoidosis Research","volume":"35","author":"Sellares","year":"2018","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref190","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00437"},{"key":"key20191023000315_ref191","doi-asserted-by":"crossref","unstructured":"Moller DR, Rybicki BA, Hamzeh NY, et al. Genetic, immunologic, and environmental basis of sarcoidosis. Ann Am Thorac Soc 2017;14(Supplement_6):429-36.","DOI":"10.1513\/AnnalsATS.201707-565OT"},{"key":"key20191023000315_ref192","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2013-101532"},{"key":"key20191023000315_ref193","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.4.348"},{"key":"key20191023000315_ref194","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2007.03.005"},{"key":"key20191023000315_ref195","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040429"},{"key":"key20191023000315_ref196","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.12.8784"},{"key":"key20191023000315_ref197","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-11-161"},{"key":"key20191023000315_ref198","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00142-09"},{"key":"key20191023000315_ref199","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.4646"},{"key":"key20191023000315_ref200","first-page":"256","article-title":"Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis","volume":"17","author":"Ebe","year":"2000","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref201","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.80"},{"key":"key20191023000315_ref202","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2012.07.001"},{"key":"key20191023000315_ref203","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2011.04456.x"},{"key":"key20191023000315_ref204","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01209-2015"},{"key":"key20191023000315_ref205","doi-asserted-by":"publisher","DOI":"10.1172\/JCI32401"},{"key":"key20191023000315_ref206","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170285"},{"key":"key20191023000315_ref207","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01516"},{"key":"key20191023000315_ref208","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01791-2015"},{"key":"key20191023000315_ref209","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805958"},{"key":"key20191023000315_ref210","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201507-1499OC"},{"key":"key20191023000315_ref211","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01124-2017"},{"key":"key20191023000315_ref212","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00092-2016"},{"key":"key20191023000315_ref213","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023185"},{"key":"key20191023000315_ref214","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1004081"},{"key":"key20191023000315_ref215","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000303"},{"key":"key20191023000315_ref216","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-0383"},{"key":"key20191023000315_ref217","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200909-1451OC"},{"key":"key20191023000315_ref218","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3655"},{"key":"key20191023000315_ref219","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00430-2019"},{"key":"key20191023000315_ref220","doi-asserted-by":"publisher","DOI":"10.1007\/s10059-013-0138-2"},{"key":"key20191023000315_ref221","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.05.010"},{"key":"key20191023000315_ref222","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200912-1855OC"},{"key":"key20191023000315_ref223","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2018.01.018"},{"key":"key20191023000315_ref224","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2018.00043"},{"key":"key20191023000315_ref225","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2002"},{"key":"key20191023000315_ref226","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.3.1483"},{"key":"key20191023000315_ref227","doi-asserted-by":"publisher","DOI":"10.4103\/1817-1737.62471"},{"key":"key20191023000315_ref228","doi-asserted-by":"publisher","DOI":"10.1378\/chest.120.3.873"},{"key":"key20191023000315_ref229","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00083404"},{"key":"key20191023000315_ref230","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2007.11.576"},{"key":"key20191023000315_ref231","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2016.06.001"},{"key":"key20191023000315_ref232","doi-asserted-by":"publisher","DOI":"10.1016\/S0012-3692(15)37649-2"},{"key":"key20191023000315_ref233","first-page":"170","article-title":"Granulomatous pulmonary angiitis in sarcoidosis","volume":"101","author":"Rosen","year":"1977","journal-title":"Arch Pathol Lab Med"},{"key":"key20191023000315_ref234","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-0324"},{"key":"key20191023000315_ref235","first-page":"108","article-title":"Pulmonary hypertension in sarcoidosis","volume":"23","author":"Baughman","year":"2006","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref236","first-page":"121","article-title":"Right heart impairment in sarcoidosis: haemodynamic and echocardiographic study","volume":"64","author":"Rizzato","year":"1983","journal-title":"Eur J Respir Dis"},{"key":"key20191023000315_ref237","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2822"},{"key":"key20191023000315_ref238","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00175907"},{"key":"key20191023000315_ref239","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01319-2015"},{"key":"key20191023000315_ref240","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2014.03.043"},{"key":"key20191023000315_ref241","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-0263"},{"key":"key20191023000315_ref242","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2010.212084"},{"key":"key20191023000315_ref243","first-page":"82","article-title":"Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapies","volume":"31","author":"Keir","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref244","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2015.08.011"},{"key":"key20191023000315_ref245","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-1881"},{"key":"key20191023000315_ref246","first-page":"139","article-title":"Ambrisentan for sarcoidosis associated pulmonary hypertension","volume":"28","author":"Judson","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref247","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.5.1481"},{"key":"key20191023000315_ref248","first-page":"110","article-title":"Inhaled iloprost for sarcoidosis associated pulmonary hypertension","volume":"26","author":"Baughman","year":"2009","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref249","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-1766"},{"key":"key20191023000315_ref250","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.09.031"},{"key":"key20191023000315_ref251","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00465-2017"},{"key":"key20191023000315_ref252","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-2569"},{"key":"key20191023000315_ref253","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-004-2480-4"},{"key":"key20191023000315_ref254","doi-asserted-by":"publisher","DOI":"10.3109\/02770903.2012.747204"},{"key":"key20191023000315_ref255","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-011-9280-9"},{"key":"key20191023000315_ref256","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00187410"},{"key":"key20191023000315_ref257","doi-asserted-by":"publisher","DOI":"10.1378\/chest.92.3.505"},{"key":"key20191023000315_ref258","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91481-6"},{"key":"key20191023000315_ref259","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2011.01.002"},{"key":"key20191023000315_ref260","doi-asserted-by":"publisher","DOI":"10.1378\/chest.82.4.430"},{"key":"key20191023000315_ref261","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(99)01334-X"},{"key":"key20191023000315_ref262","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1013171"},{"key":"key20191023000315_ref263","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(92)90086-J"},{"key":"key20191023000315_ref264","first-page":"48","article-title":"Indicators predictive of success of embolisation: analysis of 88 patients with haemoptysis","volume":"105","author":"Mossi","year":"2003","journal-title":"Radiol Med"},{"key":"key20191023000315_ref265","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.10.0659"},{"key":"key20191023000315_ref266","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.146.3.6828674"},{"key":"key20191023000315_ref267","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-009-1591-3"},{"key":"key20191023000315_ref268","doi-asserted-by":"publisher","DOI":"10.1148\/122.1.33"},{"key":"key20191023000315_ref269","first-page":"557","article-title":"[Multicenter clinical trial of itraconazole in the treatment of pulmonary aspergilloma]","volume":"72","author":"Tsubura","year":"1997","journal-title":"Kekkaku"},{"key":"key20191023000315_ref270","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-012-0391-x"},{"key":"key20191023000315_ref271","doi-asserted-by":"publisher","DOI":"10.1136\/thx.46.11.839"},{"key":"key20191023000315_ref272","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1988.tb03653.x"},{"key":"key20191023000315_ref273","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70263-H"},{"key":"key20191023000315_ref274","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.02.640"},{"key":"key20191023000315_ref275","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-1784"},{"key":"key20191023000315_ref276","first-page":"19","article-title":"The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"key20191023000315_ref277","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e3283642a7a"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.l5553","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.l5553","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T19:45:43Z","timestamp":1695325543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.l5553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":277,"alternative-id":["10.1136\/bmj.l5553"],"URL":"https:\/\/doi.org\/10.1136\/bmj.l5553","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736833154.793579447","asserted-by":"object"}]},"ISSN":["0959-8138","1756-1833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]}}}